Synthetic DNA Technologies Enable Fast & Responsive Antibody Discovery & Optimization
PEGS Boston Virtual 2020 Presentation
Dr. Aaron Sato, CSO of Twist Biopharma, presentation from PEGS Boston Virtual 2020, Synthetic DNA Technologies Enable Fast & Responsive Antibody Discovery & Optimization.
- How Dr. Sato isn’t settling for just a single phage display library, but is instead building a panel of highly diverse synthetic naïve antibody phage display libraries.
- How those libraries are yielding results even against difficult-to-drug targets.
- How we’ve taken our learnings to build the Twist Antibody Optimization (TAO) platform for antibody affinity and developability optimization.
- Why Twist Biopharma is now in a position to offer high-throughput antibody expression as a service.